Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1118940

Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug- Resistant Proteus mirabilis in a University Hospital of Split, Croatia


Rubić, Žana; Šoprek, Silvija; Jelić, Marko; Novak, Anita; Goić-Barišić, Ivana; Radić, Marina; Tambić Andrašević, Arjana; Tonkić, Marija
Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug- Resistant Proteus mirabilis in a University Hospital of Split, Croatia // Microbial Drug Resistance, 27 (2021), 2; 162-169 doi:10.1089/mdr.2020.0002 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1118940 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug- Resistant Proteus mirabilis in a University Hospital of Split, Croatia

Autori
Rubić, Žana ; Šoprek, Silvija ; Jelić, Marko ; Novak, Anita ; Goić-Barišić, Ivana ; Radić, Marina ; Tambić Andrašević, Arjana ; Tonkić, Marija

Izvornik
Microbial Drug Resistance (1076-6294) 27 (2021), 2; 162-169

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
AmpC ; CMY ; ISEcp1 ; Proteus mirabilis ; carbapenem alternatives ; multidrug-resistant

Sažetak
This study was performed to elucidate genetic relatedness and molecular resistance mechanisms of AmpC-producing multidrug-resistant Proteus mirabilis isolates in University Hospital of Split (UHS), and define efficient antibiotics in vitro. A total of 100 nonrepeated, consecutive, amoxicillin/clavulanate- and cefoxitin-resistant P. mirabilis isolates were collected, mostly from urine (44%) and skin and soft-tissue samples (30%). They were all positive in cefoxitin Hodge test and negative for extended spectrum beta- lactamase production. Pulsed field gel electrophoresis identified four clusters and two singletons, with 79% of isolates in dominant cluster. Molecular characterization and I-CeuI analysis of representatives revealed blaCMY-16 gene located on chromosome, and insertion element ISEcp1 positioned 110 pb upstream of blaCMY-16 starting codon. They also harbored blaTEM-1, except one with blaTEM-2. They were all resistant to trimethoprim-sulfamethoxazole, all but one to quinolones, and 81% to all aminoglycosides, while 77% were susceptible (S) and 22% intermediate (I) to piperacillin/tazobactam, and 4% were S and 68% I to cefepime. Only 15% were S to ceftolozane/tazobactam. Meropenem, ertapenem, ceftazidime/avibactam, temocillin, and fosfomycin were 100% efficient in vitro. This is the first report of blaCMY-16 gene in P. mirabilis from hospital samples in Croatia. The findings are in accordance with Italian and Greek reports. The clonal nature of outbreak suggests the high potential of clonal spread. Alternative agents should be considered to spare carbapenem usage.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Stomatološki fakultet, Zagreb,
KBC Split,
Klinika za infektivne bolesti "Dr Fran Mihaljević",
Medicinski fakultet, Split

Poveznice na cjeloviti tekst rada:

doi doi.org

Citiraj ovu publikaciju:

Rubić, Žana; Šoprek, Silvija; Jelić, Marko; Novak, Anita; Goić-Barišić, Ivana; Radić, Marina; Tambić Andrašević, Arjana; Tonkić, Marija
Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug- Resistant Proteus mirabilis in a University Hospital of Split, Croatia // Microbial Drug Resistance, 27 (2021), 2; 162-169 doi:10.1089/mdr.2020.0002 (međunarodna recenzija, članak, znanstveni)
Rubić, Ž., Šoprek, S., Jelić, M., Novak, A., Goić-Barišić, I., Radić, M., Tambić Andrašević, A. & Tonkić, M. (2021) Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug- Resistant Proteus mirabilis in a University Hospital of Split, Croatia. Microbial Drug Resistance, 27 (2), 162-169 doi:10.1089/mdr.2020.0002.
@article{article, author = {Rubi\'{c}, \v{Z}ana and \v{S}oprek, Silvija and Jeli\'{c}, Marko and Novak, Anita and Goi\'{c}-Bari\v{s}i\'{c}, Ivana and Radi\'{c}, Marina and Tambi\'{c} Andra\v{s}evi\'{c}, Arjana and Tonki\'{c}, Marija}, year = {2021}, pages = {162-169}, DOI = {10.1089/mdr.2020.0002}, keywords = {AmpC, CMY, ISEcp1, Proteus mirabilis, carbapenem alternatives, multidrug-resistant}, journal = {Microbial Drug Resistance}, doi = {10.1089/mdr.2020.0002}, volume = {27}, number = {2}, issn = {1076-6294}, title = {Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug- Resistant Proteus mirabilis in a University Hospital of Split, Croatia}, keyword = {AmpC, CMY, ISEcp1, Proteus mirabilis, carbapenem alternatives, multidrug-resistant} }
@article{article, author = {Rubi\'{c}, \v{Z}ana and \v{S}oprek, Silvija and Jeli\'{c}, Marko and Novak, Anita and Goi\'{c}-Bari\v{s}i\'{c}, Ivana and Radi\'{c}, Marina and Tambi\'{c} Andra\v{s}evi\'{c}, Arjana and Tonki\'{c}, Marija}, year = {2021}, pages = {162-169}, DOI = {10.1089/mdr.2020.0002}, keywords = {AmpC, CMY, ISEcp1, Proteus mirabilis, carbapenem alternatives, multidrug-resistant}, journal = {Microbial Drug Resistance}, doi = {10.1089/mdr.2020.0002}, volume = {27}, number = {2}, issn = {1076-6294}, title = {Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug- Resistant Proteus mirabilis in a University Hospital of Split, Croatia}, keyword = {AmpC, CMY, ISEcp1, Proteus mirabilis, carbapenem alternatives, multidrug-resistant} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font